Zhengqing Ouyang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhengqing Ouyang has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Prathibha Mohan
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
24 shared publications Antonija Burčul
23 shared publicationsAgnes Viale
22 shared publicationsAskan Gokce
22 shared publicationsJianan Lin
22 shared publicationsMan Jiang
22 shared publications
Latest Publications
- Open Access
- 26 March 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (10)
Targeting eIF4A-dependent translation in genetically complex sarcoma
Dedifferentiated liposarcoma (DDLS), myxofibrosarcoma (MFS), and undifferentiated pleomorphic sarcoma (UPS) are the most common types of genetically complex sarcoma. There is an urgent need to develop effective targeted therapy for these deadly sarcoma types. Despite their genetic complexity, these sarcomas share genomic alterations causing PI3K/Akt/mTOR and MAPK pathway activation, and both pathways control translation mediated by the RNA helicase eIF4A. We therefore investigated eIF4A inhibition as a therapeutic strategy. The eIF4A inhibitor CR-1-31B effectively suppressed tumor growth and induced apoptosis in DDLS, MFS, and UPS patient–derived cell lines and mouse xenografts. Transcriptome-scale ribosome footprinting identified eIF4A-dependent mRNAs such as the Hippo pathway transcriptional coactivators YAP1 (YAP) and WWTR1 (TAZ). Combined knockdown of YAP and TAZ induced apoptosis in DDLS, MFS, and UPS cell lines, and their ectopic expression partially rescued cells from apoptosis induced by CR-1-31B. Genomic analysis of patient tumors revealed that YAP and WWTR1 were frequently amplified or gained in DDLS, MFS, and UPS and were associated with worse clinical outcomes. Together, our findings identify a strategy for targeting the Hippo pathway in incurable forms of sarcoma based on inhibition of eIF4A-dependent translation of the key oncogenic transcription factors YAP and TAZ.
- 26 March 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (10)
Open AccessTargeting eIF4A-dependent translation in genetically complex sarcoma
Dedifferentiated liposarcoma (DDLS), myxofibrosarcoma (MFS), and undifferentiated pleomorphic sarcoma (UPS) are the most common types of genetically complex sarcoma. There is an urgent need to develop effective targeted therapy for these deadly sarcoma types. Despite their genetic complexity, these sarcomas share genomic alterations causing PI3K/Akt/mTOR and MAPK pathway activation, and both pathways control translation mediated by the RNA helicase eIF4A. We therefore investigated eIF4A inhibition as a therapeutic strategy. The eIF4A inhibitor CR-1-31B effectively suppressed tumor growth and induced apoptosis in DDLS, MFS, and UPS patient–derived cell lines and mouse xenografts. Transcriptome-scale ribosome footprinting identified eIF4A-dependent mRNAs such as the Hippo pathway transcriptional coactivators YAP1 (YAP) and WWTR1 (TAZ). Combined knockdown of YAP and TAZ induced apoptosis in DDLS, MFS, and UPS cell lines, and their ectopic expression partially rescued cells from apoptosis induced by CR-1-31B. Genomic analysis of patient tumors revealed that YAP and WWTR1 were frequently amplified or gained in DDLS, MFS, and UPS and were associated with worse clinical outcomes. Together, our findings identify a strategy for targeting the Hippo pathway in incurable forms of sarcoma based on inhibition of eIF4A-dependent translation of the key oncogenic transcription factors YAP and TAZ.
- Open Access
- 17 August 2025
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 19
Newly Identified Genetic Associations of Alzheimer Disease by Conditional Selective Inference: Potential Implications for the Tau Hypothesis
Over 6 million people are estimated to have been living with Alzheimer disease (AD) in 2020, with another 12 million living with Mild Cognitive Impairment (MCI). Research has been conducted to evaluate genetic links to AD, but more research is needed to improve early disease detection and improve patient outcomes. Diagnostic, demographic information, and single nucleotide polymorphism (SNP) data were collected by the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We performed LASSO regression with conditional selective inference to perform feature selection on the SNPs and other predictors (which included education, race, and marital status), which reduced the number of SNPs from 55 106 to 13 and removed all non-SNP predictors except years of education and marital status. The included SNPs reside in genes that have clinical significance and may be associated with diseases that affect cognitive performance. The results propose the alternative alleles for 7 SNPs are associated with increased risk of AD/MCI diagnosis, while 6 SNPs are associated with decreased risk of diagnosis. The results point to a new potential pathway of disease regarding the PAK5 gene and the Tau protein hypothesis, which is supported by previous research. This research may have clinical implications and should be further studied.
- 17 August 2025
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 19
Open AccessNewly Identified Genetic Associations of Alzheimer Disease by Conditional Selective Inference: Potential Implications for the Tau Hypothesis
Over 6 million people are estimated to have been living with Alzheimer disease (AD) in 2020, with another 12 million living with Mild Cognitive Impairment (MCI). Research has been conducted to evaluate genetic links to AD, but more research is needed to improve early disease detection and improve patient outcomes. Diagnostic, demographic information, and single nucleotide polymorphism (SNP) data were collected by the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We performed LASSO regression with conditional selective inference to perform feature selection on the SNPs and other predictors (which included education, race, and marital status), which reduced the number of SNPs from 55 106 to 13 and removed all non-SNP predictors except years of education and marital status. The included SNPs reside in genes that have clinical significance and may be associated with diseases that affect cognitive performance. The results propose the alternative alleles for 7 SNPs are associated with increased risk of AD/MCI diagnosis, while 6 SNPs are associated with decreased risk of diagnosis. The results point to a new potential pathway of disease regarding the PAK5 gene and the Tau protein hypothesis, which is supported by previous research. This research may have clinical implications and should be further studied.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Cancer Informatics
- Vol. 24
Unsupervised Random Forest Identifies Important Genetic Prognostic Factors for Breast Cancer Survival Time
Objective: Breast cancer is one of the most prominent and deadly diseases in the world, and its prognosis varies widely based on the expression of certain genes. Identification of these genes is important for developing and interpreting clinical prognostic tests as well as furthering our understanding of breast cancer biology. We expand on prior efforts in the field toward identifying prognostic genes, by integrating powerful statistical methods. Methods: To this end, we use an unsupervised random forest model, which allows for robust learning of non-linear gene expression/survival relationships and the ability to identify the most important genes affecting both positive and negative breast cancer prognosis. In total, 1,518 participants were considered from the METABRIC dataset, using 20,387 mRNA expression level variables and 23 clinical variables including HER2 mutation status. The top 250 & bottom 250 expressing genes and 6 clinical features were selected for the unsupervised random forest model. Results: Our research corroborates previous discoveries of 27 important prognostic genes while also identifying 3 genes as potentially novel prognostic factors. Based on gene ontology analysis, we additionally show that these genes have plausible connections to breast cancer biology that should be experimentally investigated. Conclusions: Here, we demonstrate the utility of the unsupervised random forest model over K-means clustering for identifying important genes in breast cancer.
- 1 January 2025
- Published by SAGE Publications in Cancer Informatics
- Vol. 24
Open AccessUnsupervised Random Forest Identifies Important Genetic Prognostic Factors for Breast Cancer Survival Time
Objective: Breast cancer is one of the most prominent and deadly diseases in the world, and its prognosis varies widely based on the expression of certain genes. Identification of these genes is important for developing and interpreting clinical prognostic tests as well as furthering our understanding of breast cancer biology. We expand on prior efforts in the field toward identifying prognostic genes, by integrating powerful statistical methods. Methods: To this end, we use an unsupervised random forest model, which allows for robust learning of non-linear gene expression/survival relationships and the ability to identify the most important genes affecting both positive and negative breast cancer prognosis. In total, 1,518 participants were considered from the METABRIC dataset, using 20,387 mRNA expression level variables and 23 clinical variables including HER2 mutation status. The top 250 & bottom 250 expressing genes and 6 clinical features were selected for the unsupervised random forest model. Results: Our research corroborates previous discoveries of 27 important prognostic genes while also identifying 3 genes as potentially novel prognostic factors. Based on gene ontology analysis, we additionally show that these genes have plausible connections to breast cancer biology that should be experimentally investigated. Conclusions: Here, we demonstrate the utility of the unsupervised random forest model over K-means clustering for identifying important genes in breast cancer.
- Open Access
- 18 January 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 42 (12) , 1909-1920
KARR-seq reveals cellular higher-order RNA structures and RNA–RNA interactions
RNA fate and function are affected by their structures and interactomes. However, how RNA and RNA-binding proteins (RBPs) assemble into higher-order structures and how RNA molecules may interact with each other to facilitate functions remain largely unknown. Here we present KARR-seq, which uses N3-kethoxal labeling and multifunctional chemical crosslinkers to covalently trap and determine RNA–RNA interactions and higher-order RNA structures inside cells, independent of local protein binding to RNA. KARR-seq depicts higher-order RNA structure and detects widespread intermolecular RNA–RNA interactions with high sensitivity and accuracy. Using KARR-seq, we show that translation represses mRNA compaction under native and stress conditions. We determined the higher-order RNA structures of respiratory syncytial virus (RSV) and vesicular stomatitis virus (VSV) and identified RNA–RNA interactions between the viruses and the host RNAs that potentially regulate viral replication.
- 18 January 2024
- Published by Springer Nature in Nature Biotechnology
- Vol. 42 (12) , 1909-1920
Open AccessKARR-seq reveals cellular higher-order RNA structures and RNA–RNA interactions
RNA fate and function are affected by their structures and interactomes. However, how RNA and RNA-binding proteins (RBPs) assemble into higher-order structures and how RNA molecules may interact with each other to facilitate functions remain largely unknown. Here we present KARR-seq, which uses N3-kethoxal labeling and multifunctional chemical crosslinkers to covalently trap and determine RNA–RNA interactions and higher-order RNA structures inside cells, independent of local protein binding to RNA. KARR-seq depicts higher-order RNA structure and detects widespread intermolecular RNA–RNA interactions with high sensitivity and accuracy. Using KARR-seq, we show that translation represses mRNA compaction under native and stress conditions. We determined the higher-order RNA structures of respiratory syncytial virus (RSV) and vesicular stomatitis virus (VSV) and identified RNA–RNA interactions between the viruses and the host RNAs that potentially regulate viral replication.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Statistical Applications in Genetics and Molecular Biology
- Vol. 23 (1)
Integrative pathway analysis with gene expression, miRNA, methylation and copy number variation for breast cancer subtypes
Developments in biotechnologies enable multi-platform data collection for functional genomic units apart from the gene. Profiling of non-coding microRNAs (miRNAs) is a valuable tool for understanding the molecular profile of the cell, both for canonical functions and malignant behavior due to complex diseases. We propose a graphical mixed-effects statistical model incorporating miRNA-gene target relationships. We implement an integrative pathway analysis that leverages measurements of miRNA activity for joint analysis with multimodal observations of gene activity including gene expression, methylation, and copy number variation. We apply our analysis to a breast cancer dataset, and consider differential activity in signaling pathways across breast tumor subtypes. We offer discussion of specific signaling pathways and the effect of miRNA integration, as well as publish an interactive data visualization to give public access to the results of our analysis.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Statistical Applications in Genetics and Molecular Biology
- Vol. 23 (1)
Integrative pathway analysis with gene expression, miRNA, methylation and copy number variation for breast cancer subtypes
Developments in biotechnologies enable multi-platform data collection for functional genomic units apart from the gene. Profiling of non-coding microRNAs (miRNAs) is a valuable tool for understanding the molecular profile of the cell, both for canonical functions and malignant behavior due to complex diseases. We propose a graphical mixed-effects statistical model incorporating miRNA-gene target relationships. We implement an integrative pathway analysis that leverages measurements of miRNA activity for joint analysis with multimodal observations of gene activity including gene expression, methylation, and copy number variation. We apply our analysis to a breast cancer dataset, and consider differential activity in signaling pathways across breast tumor subtypes. We offer discussion of specific signaling pathways and the effect of miRNA integration, as well as publish an interactive data visualization to give public access to the results of our analysis.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary figure S4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure S4 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules